In support of this notion, the shape of the KRAS G12C tumor size distribution 15 weeks post-tumor initiation was similar to that of the KRAS G12D tumor size distribution at the earlier 9-week timepoint (Fig. 1K). This evidence concerns the gene KRAS and neoplasm.